Adherence to ATS guidelines for hospitalized patients with community-acquired pneumonia

被引:1
作者
Malone, DC
Shaban, HM
机构
[1] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
[2] St Anthonys Cent Hosp, Centura Hlth Care, Denver, CO USA
关键词
community-acquired pneumonia; quality of care;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To compare outcomes of care and antibiotic utilization for community-acquired pneumonia (CAP) throughout a group of not-for-profit hospitals. METHODS: A retrospective chart review of patients from community hospitals with a diagnosis of pneumonia at discharge admitted from December 1997 to May 1998. Data were collected based on American Thoracic Society (ATS) criteria. RESULTS: Medical records of 330 patients were reviewed; mortality was 7%. Using ATS guidelines, 51 (15.5%) patients were not treated with recommended antimicrobial therapy. Of these patients, 14 had nonsevere cases of CAP and 37 cases were severe. Factors found to be associated with in-hospital mortality included nonadherence to ATS guidelines (OR 4.46; 95% CI 1.38 to 14.43), decreased urine output (OR 7.72; 95% CI 1.70 to 35.04), and increasing age (OR 1.06; 95% Cl 1.01 to 1.12). Significant predictors of length of stay (LOS) included age, nonadherence to ATS criteria, suspected aspiration, discharge status, low pulse oximetry on admission, decreased urine output, use of vasopressor medications, and interstitial lung disease. More than 80% of patients had at least one culture performed, but only 27.5% of these cultures were positive. The most commonly prescribed antibiotic was cefuroxime injection, representing 25% of the antibiotic orders. CONCLUSIONS: Patients with CAP treated inconsistently with ATS guidelines had a 4.46-fold higher risk of inpatient mortality and had significantly longer LOS.
引用
收藏
页码:1180 / 1185
页数:6
相关论文
共 25 条
  • [1] Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954
  • [2] Treatment of community-acquired pneumonia - IDSA guidelines
    Bernstein, JM
    [J]. CHEST, 1999, 115 (03) : 9S - 13S
  • [3] BERNSTEIN JM, 1999, CHEST, V115, P15
  • [4] BURGESS DR, 1999, PHARMACOTHERAPY, V19, P491
  • [5] A critical pathway for treatment of community-acquired pneumonia
    Burgess, DS
    Lewis, JS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (20): : 2654 - 2655
  • [6] DEMPSEY CL, 1999, P T, V24, P390
  • [7] *DEP HLTH HUM SERV, 1997, INT CLASS DIS
  • [8] ELIXAHAUSER A, AHCPR PUBL
  • [9] Severe community-acquired pneumonia - Assessment of severity criteria
    Ewig, S
    Ruiz, M
    Mensa, J
    Marcos, MA
    Martinez, JA
    Arancibia, F
    Niederman, MS
    Torres, A
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (04) : 1102 - 1108
  • [10] Processes and outcomes of care for patients with community-acquired pneumonia - Results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study
    Fine, MJ
    Stone, RA
    Singer, DE
    Coley, CM
    Marrie, TJ
    Lave, JR
    Hough, LJ
    Obrosky, DS
    Schulz, R
    Ricci, EM
    Rogers, JC
    Kapoor, WN
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (09) : 970 - 980